InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
18,857.60
(
0.00%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
74.06
(
2.32%
)
Bitcoin
62,166.97
(
0.80%
)
Post# of 365614
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jimmybob

Send PM Follow Ignore
Followers 1879
Posts 138313
Boards Moderated 5
Alias Born 01/03/2007

jimmybob

Re: jimmybob post# 320512

Tuesday, 12/12/2017 7:49:08 AM

Tuesday, December 12, 2017 7:49:08 AM

Post# of 365614
Global Blood Therapeutics price target raised to $79 from $53 at Oppenheimer
Oppenheimer analyst Mark Breidenbach raised his price target for Global Blood Therapeutics to $79 from $53 given new clinical data and improved clarity on the performance of the Patient Reported Outcome instrument. The analyst reiterates an Outperform rating on the shares

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up